The objective of this prospective observational study was to establish the prevalence of carotid atherosclerosis in an asymptomatic diabetic population and to determine predictive factors for a screening optimization. A total of 300 consecutive type-2 diabetic subjects (166 males, 134 females) underwent a physical examination and duplex carotid scanning. Patients with a recent cerebrovascular event (Յ6 weeks) or previous carotid surgery were excluded. The prevalence of carotid stenosis Ն60% or occlusion was 4.7%; the prevalence of carotid atherosclerosis was 68.3%. Risk factors for stenosis Ն60% or occlusion were the presence of diabetic retinopathy (OR: 3.62; 95% CI: 1.12-11.73), ankle-brachial index (ABI) Ͻ0.85 (OR: 3.94; 95% CI: 1.21-12.84) and a personal history of neurological disorders (OR: 4.54; 95% CI: 1.16-17.81). Being female was a protective factor (OR: 0.09; 95% CI: 0.01-0.78). The two factors in the analysis limited to the male population were an ABI Ͻ 0.85 (OR: 3.66; 95% CI: 1.04-12.84) and a personal history of coronary heart disease (OR: 3.34; 95% CI: 1.01-11.01). If male diabetics without either of these two factors are excluded, the negative predictive value for carotid stenosis is 96.6%. In conclusion, the prevalence of atherosclerotic carotid disease in diabetic patients is high. In these patients, the probability of finding Ͼ60% stenosis is highest among men with a history of coronary heart disease or an ABI Ͻ0.85.
Introduction
Diabetes is a well-known risk factor for cardiovascular diseases. The prevalence of diabetes is dramatically increasing in western populations; currently 20 million individuals have diabetes in the USA, of whom more than 5 million remain undiagnosed. 1 The risk of coronary disorders or stroke in diabetic patients is three times that in individuals without this condition. 2, 3 Stroke is the third leading cause of death in western countries and is associated with a high level of disability and causes a tremendous financial burden. Carotid artery stenosis is one of the main causes of stroke. Duplex scanning allows efficient screening for carotid artery disease, but a trained physician or technologist is required and the equipment is still expensive. In most of the guidelines regarding diabetes, general screening for carotid disease is not recommended, mainly due to the cost and the low return when prevalence of carotid disease is low. 4, 5 Focused screening is recommended where there is a history of neurological symptoms or cervical bruit. 5 On the other hand, the Asymptomatic Carotid Atherosclerosis Study (ACAS) 6 and the Asymptomatic Carotid Surgery Trial (MRC ACST) 7 demonstrated a positive effect of carotid endarterectomy in asymptomatic patients with carotid stenosis Ն60%, with a prerequisite surgical complications rate under 3%. In daily practice, many physicians extend screening to a larger subgroup of diabetics.
The objectives of this study were (1) to determine the prevalence of high-grade carotid stenosis in patients with type-2 diabetes without any history of cerebrovascular disease and (2) to increase the efficiency of duplex screening by identifying a high-risk subgroup with a predictive model. were systematically included. These patients were referred to our department of internal medicine which takes care of diabetic patients as a university hospital center. They were either hospitalized for an accurate equilibration of their disease or seen in the outpatient clinic for a biennial check-up. In addition to type-2 diabetes, the inclusion criteria were age Ͼ18 years, life expectancy Ͼ12 months and informed consent agreement. All the patients with a previous history of recent (Ͻ6 weeks) stroke or transient ischemic attack, a history of carotid surgery or cervical radiotherapy were excluded from this study. Personal and family history and medications were recorded.
Subjects were considered to have hypercholesterolemia if they had a total blood cholesterol Ͼ240 mg/dl or were taking lipid-lowering drugs. They were considered as hypertensive if they reported a history of hypertension or were taking antihypertensive drugs. Patients were categorized as 'non-smokers' or 'ever smokers'. Subjects were considered to have coronary heart disease (CHD) if they had a history of myocardial infarction, angina pectoris, ischemic disorders on the electrocardiogram, or were taking antiangina drugs. Subjects were considered to have peripheral arterial disease (PAD) if they had a history of claudication or vascular surgery or an abnormal ankle-brachial index (ABI). The normal ABI range in this study was determined as 0.85-1.5. Albuminuria was measured on 24-hour urine and microalbuminuria was considered for albumin excretion Ն30 mg/24 hour. All the subjects underwent fundus examination by an ophthalmologist and were classified as 'diabetic retinopathy' (either proliferative or non-proliferative) or 'no diabetic retinopathy'.
For each leg, the ABI was determined by dividing the mean of the posterior tibial and dorsalis pedis systolic pressures by the mean of the systolic pressures of both arms, except when the difference between both arms exceeded 15 mmHg. In this latter case, only the highest of both values was taken for the denominator. The validation of the protocol for the ABI measurement has been extensively published elsewhere. 8 The ultrasound screening method for cervical vascular disorders included a continuous wave Doppler followed by a duplex study (ATL HDI 3000 or ATL HDI 5000, Bothell, WA, USA) of both the carotid and vertebral arteries. All the investigations were performed by experienced vascular physicians. The duplex stenosis determination in our laboratory has previously been validated versus surgical pieces after endarterectomy, and already published elsewhere. 9 Briefly, in none of the 50 cases of carotid endarterectomy was our Duplex estimation of stenosis overestimated. Stenosis was considered Ն60% when the maximal velocity within the lesion was Ͼ2.6 m/s and the end-diastolic velocity Ͼ0.7 m/s. 10 The artery was considered as occluded in the absence of any Doppler signal, either by pulsed or color Doppler. According to the results of the carotid ultrasound screening in this study, subjects were classified as normal (no atherosclerotic lesions), stenosis Ͻ60% (small plaques up to Ͻ60% stenosis), and stenosis Ն60% (including occlusion).
Statistical analysis
Comparisons were performed with Student's t-test for continuous and the chi-squared analysis for discrete variables. All the factors presented in Table 1 were included in the univariate analysis. Multivariate analysis was performed using multiple logistic regression. All the factors with a p-value Ͻ0.25 were included in the multivariate analysis. A p-value Ͻ0.05 was considered statistically significant. Age was first analyzed as a continuous variable then as a discrete one with a cut-off point at 70 years. Two analyses were performed: first, we compared subjects with normal cervical arteries versus subjects with carotid lesions (plaque or stenosis); the second analysis compared subjects with no or low-grade stenosis (Ͻ60%) versus those with high-grade stenosis (Ն60%). Finally, we studied the value of screening limited to subgroups selected according to the predictive factors of Ն60% stenosis.
Results

Patient demographic data
A total of 300 consecutive subjects were included in the analysis. The mean age was 61.7 Ϯ 11.5 years (range: 33-88) in the male population and 63.5 duration of diabetes was 11 Ϯ 9.2 years (range: 1-40).
The main population data are presented in Table 1 .
Overall cervical screening results
Out of the 300 subjects who underwent the duplex scan investigation, 205 (68.3%) were abnormal; 191 (63.6%) had Ͻ60% stenosis and 14 (4.7%) presented with Ն 60% stenosis (seven with 60-99% stenosis and seven occlusions). Figure 1 presents the results according to age categories.
Relationship between risk factors and presence of carotid plaque or stenosis
The results of the univariate analysis are presented in Table 2 . Ten factors were identified. In the multivariate analysis, six factors appeared to be independently predictive ( Table 3 ). An age Ͼ70 years, a personal history of hypertension, CHD, diabetic retinopathy, or familial history of diabetes were predictive of a higher risk of carotid artery lesions, whereas a BMI Ͼ27 kg/m 2 seemed to be protective. Table 4 ). The presence of diabetic retinopathy, an ABI Ͻ0.85 and a personal history of neurological disorders or bruit remained predictive of stenosis or occlusion ( Table 5 ). Female sex was a protective factor. As the female prevalence of Ն60% carotid stenosis was limited we focused our analysis on the male population. The independent predictors of stenosis or occlusion were a personal history of coronary disease (OR: 3.34; 95%CI: 1.01-11.01, p ϭ 0.046) and an ABI Ͻ0.85 (OR: 3.66; 95% CI: 1.04-12.84, p ϭ 0.042). Seventy-nine males (47.6%) presented one of these two criteria. The distribution of male individuals was studied in order to determine the diagnostic characteristics of a strategy where the presence of either criteria would be a prerequisite to the performance of cervical duplex ( Table 6 ). The sensitivity of this mode of selection prior to cervical duplex was 77%, the specificity at 54.9%, the positive predictive value at 12.7% and the negative predictive value at 96.6%. Males without at least one of these two factors had a very low probability of high-grade carotid stenosis or occlusion (3.4% vs 12.7% in males with one or both of these factors, p Ͻ 0.05).
Discussion
Previous studies have demonstrated the efficiency of screening for symptomatic carotid artery disease in order to prevent stroke. Conversely, controversy remains on the appropriateness of screening asymptomatic subjects. The positive predictive value of screening depends on the prevalence of carotid artery stenosis in the population. In the general population the prevalence of carotid artery stenosis Ͼ50% ranges between 2% in Italy 11 and 7% for women and 9% for men in the Framingham study. 12 In our study, limited to a diabetic population managed in a university hospital, we found a 4.7% prevalence of carotid artery stenosis Ն60%, which is close to the general population. Mass screening for carotid artery stenosis is not recommended. In a study estimating the prevalence of carotid artery stenosis Ͼ50% up to 8%, Hill 13 considered that it was necessary to screen up to 850-1500 patients in order to prevent one stroke. As the prevalence of high-grade stenosis in our population was even lower, we may conclude that systematic screening in the diabetic population is not cost-effective. Diabetes was not predictive of carotid artery atherosclerosis in the Framingham 12 and Troms 14 studies. In the Troms study, male gender was an independent predictor of carotid atherosclerosis. 14 was a protective factor for high-grade stenosis. More surprisingly, our data suggest a lower prevalence of carotid plaque in obese subjects. A similar trend has already been reported in post-menopausal women 15 as well as in a Mexican-American population. 16 In contrast, BMI was positively correlated with the probability of carotid plaque in another general population study. 17 We cannot exclude a systematic bias, based on the mode of selection of our patients. In addition, the relationship between obesity and carotid atherosclerosis seems to be mainly related to central obesity and visceral fat. 18 We do not have these data in our study. Further investigations are needed to elucidate this relationship.
The main goal of our study was to define the subgroup of diabetics who may benefit from screening. Similarly, other authors have focused their research on carotid screening in a selected population. In a population study, Rockman et al 19 found a 18.2% prevalence of asymptomatic carotid artery stenosis in cases of heart disease; patients with both hypertension and heart disease had a 22.1% prevalence. Regarding PAD patients, the overall prevalence of asymptomatic carotid artery stenosis was 14% in the SMART study. 20 Three factors, higher age, lower weight and higher diastolic blood pressure, were independently associated with stenosis. The prevalence increased from 8% in those with one risk factor to 50% in those with three. In our present study, a personal history of CHD and symptomatic or asymptomatic PAD were associated with an increased risk of carotid stenosis in the male population. Screening therefore seems inappropriate in other subgroups due to a very low probability of carotid stenosis.
The clinical consequences of screening asymptomatic carotid stenosis are limited. In the Asymptomatic Carotid Atherosclerosis Study, the 5-year absolute risk reduction for death and stroke associated with surgery was only 5.8%. 6 The relative risk reduction for stroke and death in men treated with surgery was at 66% in men but only 17% in women. However, this difference was not statistically significant. Whitty et al 21 estimated that screening for asymptomatic carotid artery stenosis below a 20% prevalence cannot be recommended, and may be harmful. Even at 20% prevalence, the number of strokes prevented per 10 000 subjects screened was 112. In the present study, the prevalence of carotid stenosis was 12.7% in the male high-risk group (with an abnormal ABI and/or history of CHD). Thus, as the indication of asymptomatic carotid revascularization keeps on generating debates, screening for asymptomatic carotid stenosis is similarly controversial. 13, 21, 22 Additionally, in a recent national audit on complications after carotid endarterectomy, 23 diabetes was associated with a higher risk of peri-operative complication.
The results of this study also indicate that the prevalence of carotid atherosclerosis is high in diabetic subjects as more than 68% had lesions. De Angelis et al 24 had previously described a higher prevalence of carotid atherosclerosis in type-2 diabetic subjects compared with non-diabetic subjects. Carotid atherosclerosis was identified as a risk factor for CHD in the Cardiovascular Health Study. 25 In the Insulin Resistance Atherosclerosis Study, diabetic subjects without CHD had similar carotid intima-media thickness compared with non-diabetic subjects with a history of CHD. 26 These data suggest that all diabetic subjects may be treated the same as secondary prevention for CHD with statins and antiplatelet drugs. In the Medical Research Council / Heart Protection Study, 27 simvastatin reduced the rate of first occurrence of major vascular events by 22% regardless of the baseline LDL cholesterol or history of coronary disease. Recently, the American Diabetes Association recommended the use of aspirin for primary prevention in type-2 diabetics at increased cardiovascular risk (age Ͼ40, family history of cardiovascular disease, hypertension, smoking, dyslipidemia, albuminuria). 28 Taking into account all these data, the diagnosis of carotid plaques (Ͻ60% stenosis) has a non-significant effect on the optimal management of diabetic patients, and future studies in this field should, as in our first aim, focus on the determination of criteria predictive of high-grade (Ն60%) carotid stenosis, which could then potentially be considered for additional specific treatment, namely a carotid surgery, or alternatively a carotid angioplasty.
Our study has some limitations. First, the diabetic patients studied were all referred to a medical department specifically managing these patients, and therefore the results obtained here cannot be extended to all diabetic subjects. However, it is reasonable to consider these patients at a higher level of cardiovascular risk compared to overall diabetic subjects, and consequently the prevalence of high-grade carotid stenosis could be even lower in an extended population of diabetic subjects. Conversely, as we excluded symptomatic patients as well as those with carotid surgery history, we depleted to some extent our diabetic group of high-risk patients. We cannot determine the effect of this selection criteria on our results. However, we attempted to focus our study on those diabetic subjects who had no reason for referral to a vascular laboratory other than being diabetic per se. Finally, other ABI thresholds could be suggested for this study (ie 0.9 for the lower threshold and 1.4 for the higher threshold). Presently, there is no consensus on the actual thresholds of ABI, 29 and our thresholds correspond to another report on the probability of carotid stenosis according to ABI values in a different population. 9 As the prevalence of carotid disease is proportional to PAD severity, 9, 30 it is plausible that by choosing a more lenient criteria we would weaken the predictive value of ABI to determine Ն60% carotid stenosis.
In conclusion, in diabetic patients, the field for screening carotid disease is narrow. Among patients with type-2 diabetes mellitus, the probability of finding Ն60% stenosis is highest among men with a history of CHD or an ABI Ͻ0.85.
